G Medical Innovations, MiCare Path Team Up on RPM Solutions

G Medical Innovations Holdings Ltd. and MiCare Path are partnering to integrate their remote patient monitoring solutions.

As part of the collaboration, G Medical Innovations’ hardware devices will be integrated with MiCare’s software platform and visualization tools to provide remote patient monitoring services. MiCare Path brings to the partnership its large hospital system presence and optimized patient care platform to drive digital science to deliver the future of healthcare. G Medical Innovations was a chosen partner for MiCare Path due to its scalable solution for building and fostering health technology.

“This collaboration with MiCare Path, allows us to pivot towards innovative approaches in remote patient monitoring while delivering an automated comprehensive system of patient engagement, behavioral change, and interactive communication,” G Medical Innovations CEO Dr. Yacov Geva said. The company has patient monitoring services located in Austin, Texas, and Memphis, Tenn.  
 
Under the terms of the agreement, G Medical Innovations will be responsible for the server integration of its devices into MiCare’s platform. MiCare will be responsible for all support and information technology integration pertaining to their patient application. The agreement has a term until Dec. 31, 2024, unless terminated earlier, and will automatically renew for one year thereafter (repeating each calendar year).
 
“By integrating MiCare Path’s virtual health solutions with G Medical’s global health solutions and devices, physicians and patients will benefit from the next-generation care driving better outcomes for patients across all services,” MiCare Path Founder/CEO Scott Laster stated. “The G Medical collaboration will allow for a total remote patient monitoring (RPM) and remote therapeutic monitoring (RTM) solution from service to exceptional future solutions.”
 
G Medical Innovations Holdings Ltd. develops next-generation mHealth and telemedicine solutions and monitoring service platforms. The company’s solutions and services can empower consumers, patients, and providers to better monitor, manage and improve clinical and personal health outcomes, especially for those who suffer from cardiovascular disease (or CVD), pulmonary disease, and diabetes. The company’s current product lines consist of its Prizma medical device (or Prizma), a clinical-grade product that can transform almost any smartphone into a medical monitoring device, enabling both healthcare providers and individuals to monitor, manage and share a wide range of vital signs and biometric indicators; its Extended Holter and Monitoring Cardiac Telemetry Patch services, utilizing a multi-channel patient-worn biosensors, with algorithms for real time analysis and transmission that captures electrocardiography (i.e. ECG) data continuously, including QT Syndrome Prolongation Detection. In addition, the company is developing its Wireless Vital Signs Monitoring System (or VSMS), which is expected to provide full, continuous, and real-time monitoring of a wide range of vital signs and biometrics. Its monitoring services include provision of Independent Diagnostic Testing Facility (i.e., IDTF) monitoring services and private monitoring services.
 
In the second half of 2022, G Medical Innovations expanded its business activities into a new business area, at-home laboratory testing kits. In the third quarter of 2023, the company expects that users will be able to purchase a sample collection kit at retail stores or online and collect their sample from the comfort and privacy of their home and send it via mail to the firm’s certified lab for analysis. G Medical Innovations has developed 31 types of tests kits which can test a wide range health issued related to hormones, sexual transferred disease, colon cancer, nutrition, food sensitivities and allergies. In addition, the company’s pipeline includes development of additional kits for drug detection, heavy metal and toxicology. Data received from both vital signs and lab tests reflects the vision of G Medical Innovations, which is to allow users to create their personal electronic medical records and manage their health in one location which is available for them anywhere and anytime without dependency on any medical organization.
 
MiCare Path provides real-time connectivity solutions for an ever-growing patient population. MiCare Path is a reimbursable, integrated mobile health (mHealth) platform delivering improved outcomes with data-driven decisions, personalized patient-centered education and care paths promoting clinical efficiencies for a better patient experience. They empower people to take control of their health through innovative monitoring and management of all health conditions by removing barriers to patient engagement and leading to better health.